VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRMDCorMedix Inc.
$7.85$616M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCRMDQuarterly Financials

CorMedix Inc. (CRMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

CorMedix Inc. (CRMD) quarterly income statement — complete revenue, gross profit & net income history

CRMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue127.43M128.62M104.28M39.74M39.08M31.21M11.46M806.12K0000
Revenue Growth %226.05%312.1%810.22%4829.4%------100%-100%-100%
Cost of Goods Sold22.3M21.31M11.19M1.86M1.6M1.18M686.6K509.84K818.54K53.51K51.86K50.75K
COGS % of Revenue17.5%16.57%10.74%4.69%4.09%3.77%5.99%63.25%----
Gross Profit105.12M107.31M93.08M37.87M37.48M30.03M10.77M296.28K-818.54K-53.51K-51.86K-50.75K
Gross Margin %82.5%83.43%89.26%95.31%95.91%96.23%94.01%36.75%----
Gross Profit Growth %180.44%257.28%764.3%12683.29%4679.49%56231.68%20865.72%683.83%-1555.45%-282.64%-1069.75%-342.57%
Operating Expenses41.46M48.18M41.73M18.33M17.36M17.1M14.06M15.6M15.89M15.62M10.42M11.75M
OpEx % of Revenue32.54%37.46%40.02%46.13%44.42%54.78%122.7%1934.84%----
Selling, General & Admin34.25M39.58M36.64M15.89M14.17M15.37M13.33M14.95M15.05M13.33M7.8M7.01M
SG&A % of Revenue26.88%30.78%35.13%39.98%36.25%49.25%116.35%1854.08%----
Research & Development7.21M8.6M5.1M2.44M3.19M1.73M727.12K650.99K837.45K2.29M2.66M4.79M
R&D % of Revenue5.66%6.69%4.89%6.15%8.17%5.53%6.35%80.76%----
Other Operating Expenses000000000000
Operating Income63.66M59.13M51.35M19.54M20.13M12.94M-3.29M-15.3M-16.7M-15.67M-10.47M-11.8M
Operating Margin %49.96%45.97%49.24%49.18%51.5%41.45%-28.69%-1898.09%----
Operating Income Growth %216.31%357.07%1661.93%227.73%220.48%182.56%68.59%-29.62%-51.62%-86.77%-50.35%-43.25%
EBITDA74.2M69.56M55.14M19.71M20.29M13.07M-3.21M-15.22M-16.68M-15.65M-10.45M-11.79M
EBITDA Margin %58.23%54.08%52.88%49.59%51.91%41.88%-28.02%-1888.55%----
EBITDA Growth %265.76%432.22%1817.68%229.44%221.61%183.51%69.28%-29.16%-52.1%-87.05%-50.55%-43.94%
D&A (Non-Cash Add-back)10.54M10.43M3.79M162.94K161.94K133.68K77.41K76.87K21.83K18.67K17.79K17.43K
EBIT63.66M58.26M53.52M20.36M20.65M13.47M-2.77M-14.14M-15.85M-14.75M-9.73M-11.27M
Net Interest Income0-927.1K612.03K822.28K556.79K500.38K543.85K650.81K847.35K913.49K752.13K544.33K
Interest Income0889.98K1.56M828.95K566.8K510.38K553.86K657.37K857.19K920.04K765.24K550.18K
Interest Expense01.82M948.24K6.67K10.01K10.01K10.01K6.56K9.84K6.56K13.11K5.85K
Other Income/Expense-8.01M-2.68M1.23M805.98K518.62K528.4K510.52K1.15M843.34K914.72K722.93K530.96K
Pretax Income55.65M56.45M52.58M20.35M20.64M13.46M-2.78M-14.15M-15.86M-14.75M-9.74M-11.27M
Pretax Margin %43.67%43.89%50.42%51.21%52.82%43.14%-24.24%-1755.51%----
Income Tax17.04M42.43M-55.99M521.51K0000-1.39M000
Effective Tax Rate %30.63%75.16%-106.49%2.56%0%0%0%0%8.79%0%0%0%
Net Income38.6M14.02M108.56M19.83M20.64M13.46M-2.78M-14.15M-14.47M-14.75M-9.74M-11.27M
Net Margin %30.29%10.9%104.11%49.9%52.82%43.14%-24.24%-1755.51%----
Net Income Growth %86.98%4.13%4009.63%240.11%242.71%191.26%71.5%-25.53%-36.9%-79.73%-42.18%-48.24%
Net Income (Continuing)38.6M14.02M108.56M19.83M20.64M13.46M-2.78M-14.15M-14.47M-14.75M-9.74M-11.27M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)0.420.151.260.280.300.22-0.05-0.25-0.25-0.26-0.17-0.25
EPS Growth %40%-31.82%2769.49%212%220%184.62%72.24%0%-102.56%-36.84%-6.25%-31.58%
EPS (Basic)0.490.181.420.290.320.22-0.05-0.25-0.25-0.26-0.17-0.25
Diluted Shares Outstanding92.98M93.92M86.21M71.92M68.98M61.51M58.83M57.62M57.5M57.39M56.55M45.37M
Basic Shares Outstanding79.51M78.84M75.93M67.93M65.24M61.51M58.83M57.62M57.5M57.39M56.55M45.37M
Dividend Payout Ratio------------